Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.19.2
Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
May 31, 2019
May 31, 2018
May 31, 2019
May 31, 2018
SALES $ 105,769 $ 138,742 $ 116,876 $ 166,858
COST OF SALES (75,284) (98,472) (80,833) (119,213)
GROSS PROFIT 30,485 40,270 36,043 47,645
EXPENSES:        
Depreciation 7,843 3,406 17,021 6,759
Amortization of patent rights 1,833   3,666  
Foreign currency translation gain (29,254) (19,627) (15,721) (11,600)
Selling, general and administration 728,893 415,425 1,826,861 705,868
TOTAL OPERATING EXPENSES 709,315 399,204 1,831,827 701,027
LOSS FROM OPERATIONS (678,830) (358,934) (1,795,784) (653,382)
Accretion (202,202) (29,363) (305,060) (58,111)
Change in fair value of derivative liabilities 250,337 (62,740) 645,767 (61,349)
Other expense- Interest (88,036) (33,272) (147,426) (67,179)
LOSS BEFORE INCOME TAXES (718,731) (484,309) (1,602,503) (840,021)
NET LOSS (718,731) (484,309) (1,602,503) (840,021)
Foreign exchange translation adjustment for the period (24,379) (1,679) (28,119) (2,253)
COMPREHENSIVE LOSS $ (743,110) $ (485,988) $ (1,630,622) $ (842,274)
Loss per share - basic and diluted $ (0.007) $ (0.005) $ (0.016) $ (0.009)
Weighted average number of common shares outstanding 103,632,174 93,295,626 103,040,621 93,156,427